Company Financials

Catalyst Pharmaceuticals, Inc. Financials

United States dollar

business Catalyst Pharmaceuticals, Inc. Company Profile

Main Stock Listing

NASDAQ: CPRX

Market Capitalization $2.85 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 13.54
Forward PE 8.96
Price to Sales TTM $4.92
Price to Book MRQ $3.10
Enterprise to Revenue 3.73
Enterprise to EBITDA 7.28

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 37.63%
Operating Margin 44.66%
Return on Assets TTM 17.74%
Return on Equity TTM 27.52%

Income Statement

Revenue TTM $578,195,968
Revenue per Share TTM $4.76
Quarterly Revenue Growth 15.30%
Gross Profit TTM $480,673,984
EBITDA $292,244,000
Net Income to Common TTM $217,564,000
Diluted EPS TTM $1.71
Quarterly Earnings Growth YoY 20.30%

Balance Sheet

Total Cash MRQ $689,891,968
Total Cash per Share MRQ $5.61
Total Debt MRQ $
Total Debt to Equity MRQ 0.31
Current Ratio MRQ 6.62
Book Value per Share MRQ $7.47

Cash Flow

Operating Cash Flow TTM $234,656,000
Levered Free Cash Flow TTM $181,113,376

CPRX Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 123,264,583
Float Shares 115,347,130
Avg 10 Volume 1,037,170
Avg 30 Volume None
Shares Short 7,896,866
Short Ratio 6.11
Short % of Shares 8.20%
% Held by Insiders 6.11%
% Held by Institutions 87.06%

Stock Price Summary

Beta 0.68
Fifty Two Week Low $19.05
Fifty Two Week High $26.58
Fifty Two Week Change 12.79%
Day 50 MA $22.72
Day 200 MA $22.24

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date